Prognostic Significance of Biomarkers The quest for understanding the prognosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) has intensified in […]
Prognosis biomarkers in MOGAD: What can we learn from observational studies? Read Post »
Non-Sensorimotor Symptoms Overview Chronic inflammatory demyelinating polyneuropathy (CIDP) is primarily recognized for its motor and sensory impairments; however, it also
Non-sensorimotor symptoms in chronic inflammatory demyelinating polyneuropathy Read Post »
Cognition in Functional Motor Symptoms Functional motor symptoms (FMS) manifest as involuntary movements or motor dysfunctions that lack a neurological
Electrophysiological Characteristics Demyelinating leprosy neuropathy exhibits distinct electrophysiological patterns that can significantly aid in understanding the underlying nerve impairment associated
Demyelinating Leprosy Neuropathy: An Unusual and Misleading Electrophysiological Pattern Read Post »
Study Overview This study explores an unusual manifestation of Guillain-Barré Syndrome (GBS), specifically highlighting cases where patients present with bilateral
Understanding Demyelinating Diseases Demyelinating diseases represent a group of neurological disorders characterized by the loss or damage of the myelin
ACR Appropriateness Criteria Demyelinating Diseases Read Post »
Study Overview This preliminary study examines the effects of sclerotherapy in managing chronic venous insufficiency (CVI) at the Abidjan Heart
Real-World Efficacy of Rituximab Rituximab, a monoclonal antibody targeting CD20, is primarily known for its use in certain hematological malignancies
Real-World Efficacy of Rituximab Rituximab, a chimeric monoclonal antibody, has gained attention in neuroimmunology for its impact on various neuroinflammatory
Demyelinating Diseases Overview Demyelinating diseases are a group of neurological disorders characterized by the damage or destruction of myelin, the
ACR Appropriateness Criteria Demyelinating Diseases Read Post »
